Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
99
Views
16
CrossRef citations to date
0
Altmetric
Review

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors

Bilal Zulfiqar1 Healthcare Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), IslamabadCorrespondence[email protected]
,
Amnah Mahroo1 Healthcare Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad
,
Kaenat Nasir1 Healthcare Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad
,
Rai Khalid Farooq2 Department of Physiology, Army Medical College, National University of Medical Sciences, Rawalpindi, Pakistan
,
Nasir Jalal3 Department of Molecular and Cellular Pharmacology, Health Sciences Platform, Tianjin University, Tianjin, People’s Republic of China
,
Muhammad Usman Rashid4 Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore, Pakistan
&
Kashif Asghar1 Healthcare Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad;4 Basic Sciences Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore, PakistanCorrespondence[email protected]
 show all
Pages 463-476 | Published online: 21 Jan 2017

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Shuang Gao, Xiaohui Cheng & Jinhua Li. (2019) Lipid nanobubbles as an ultrasound-triggered artesunate delivery system for imaging-guided, tumor-targeted chemotherapy. OncoTargets and Therapy 12, pages 1841-1850.
Read now
Christian Klein, Marina Bacac, Pablo Umana & Günter Fingerle-Rowson. (2017) Combination therapy with the type II anti-CD20 antibody obinutuzumab. Expert Opinion on Investigational Drugs 26:10, pages 1145-1162.
Read now
Michael J. Flynn & James M.G. Larkin. (2017) Novel combination strategies for enhancing efficacy of immune checkpoint inhibitors in the treatment of metastatic solid malignancies. Expert Opinion on Pharmacotherapy 18:14, pages 1477-1490.
Read now

Articles from other publishers (13)

Ogochukwu O. Izuegbuna. (2022) Polyphenols: Chemoprevention and therapeutic potentials in hematological malignancies. Frontiers in Nutrition 9.
Crossref
Xinchun Zhao, Yujia Jiang, Ming Xu, Jin Hu, Nan Feng, Huifang Deng, Chong Lu & Tao Huang. (2022) Indoleamine 2,3-dioxygenase 1 regulates breast cancer tamoxifen resistance through interleukin-6/signal transducer and activator of transcription. Toxicology and Applied Pharmacology 440, pages 115921.
Crossref
Yixuan Guo, Yu Liu, Wei Wu, Daishun Ling, Qiao Zhang, Peng Zhao & Xi Hu. (2021) Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy. Biomaterials 276, pages 121018.
Crossref
Shan Gao, Xiaoye Yang, Jiangkang Xu, Na Qiu & Guangxi Zhai. (2021) Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment. ACS Nano 15:8, pages 12567-12603.
Crossref
Alka Mukne, Misbah Momin, Parag Betkar, Tanvi Rane & Saurabh Valecha. 2021. Evidence Based Validation of Traditional Medicines. Evidence Based Validation of Traditional Medicines 211 248 .
Aline de Souza, Megumi Nishitani Yukuyama, Eduardo José Barbosa, Lis Marie Monteiro, Ana Cristina Breithaupt Faloppa, Leandro Augusto Calixto, Gabriel Lima de Barros Araújo, Nikoletta Fotaki, Raimar Löbenberg & Nádia Araci Bou-Chacra. (2020) A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis. Colloids and Surfaces B: Biointerfaces 193, pages 111097.
Crossref
Lien Lybaert, Karim Vermaelen, Bruno G. De Geest & Lutz Nuhn. (2018) Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 289, pages 125-145.
Crossref
Umesh C. Gupta, Subhas C. Gupta & Shayle S. Gupta. (2018) The Under appreciated Role of Lifestyle and Nutrition in Cancer Prevention, Genesis, and Treatment. Journal of Cancer Research Updates 7:4, pages 119-133.
Crossref
Yu‐Qing Xie, Lixia Wei & Li Tang. (2018) Immunoengineering with biomaterials for enhanced cancer immunotherapy. WIREs Nanomedicine and Nanobiotechnology 10:4.
Crossref
Jevgenijs Kuznecovs, Maxim Vorona, Ilona Domraceva, Iveta Kanepe-Lapsa, Marina Petrova, Edvards Liepins, Sergey Belyakov, Ainars Leonchiks & Grigory Veinberg. (2018) Synthesis and study of new 5-substituted 1-acetyl-4-phenyl-3-pyrrolin-2-ones as potential antitumor agents. Chemistry of Heterocyclic Compounds 54:5, pages 514-519.
Crossref
Alessandro Poggi, Serena Varesano & Maria Raffaella Zocchi. (2018) How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. Frontiers in Immunology 9.
Crossref
Lilla Hornyák, Nikoletta Dobos, Gábor Koncz, Zsolt Karányi, Dénes Páll, Zoltán Szabó, Gábor Halmos & Lóránt Székvölgyi. (2018) The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy. Frontiers in Immunology 9.
Crossref
Wantong Song, Sara N. Musetti & Leaf Huang. (2017) Nanomaterials for cancer immunotherapy. Biomaterials 148, pages 16-30.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.